Buprenorphine Transdermal and Nuwiq recombinant
Determining the interaction of Buprenorphine Transdermal and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Transdermal-NuZole
- Buprenorphine Transdermal-Nuzyra
- Buprenorphine Transdermal-Nuzyra (Omadacycline Injection)
- Buprenorphine Transdermal-Nuzyra (Omadacycline Tablets)
- Buprenorphine Transdermal-Nuzyra Intravenous
- Buprenorphine Transdermal-Nuzyra oral/injection
- Nuwiq recombinant-Buprenorphine Transdermal Patch
- Nuwiq recombinant-Buprenorphine transdermal skin patch
- Nuwiq recombinant-Buprenorphine, Buprenorphine Hydrochloride
- Nuwiq recombinant-Buprenorphine/naloxone Oromucosal, Sublingual
- Nuwiq recombinant-Buproban
- Nuwiq recombinant-Bupropion